Sastasundar Ventures Limited (NSE:SASTASUNDR)
India · Delayed Price · Currency is INR 284.85
-2.15 (-0.75%)
Feb 19, 2026, 2:06 PM IST
Sastasundar Ventures Market Cap
Sastasundar Ventures has a market cap or net worth of 9.13 billion as of February 18, 2026. Its market cap has increased by 0.38% in one year.
Market Cap
9.13B
Enterprise Value
10.89B
Revenue
12.78B
Ranking
n/a
PE Ratio
35.10
Stock Price
284.85
Market Cap Chart
Since October 5, 2010, Sastasundar Ventures's market cap has increased from 3.54B to 9.13B, an increase of 157.75%. That is a compound annual growth rate of 6.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 9.25B | -1.44% |
| Dec 31, 2025 | 9.39B | -6.86% |
| Dec 31, 2024 | 10.08B | -22.76% |
| Dec 29, 2023 | 13.05B | 45.93% |
| Dec 30, 2022 | 8.94B | -42.11% |
| Dec 31, 2021 | 15.45B | 276.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.07T |
| Divi's Laboratories | 1.63T |
| Apollo Hospitals Enterprise | 1.10T |
| Cipla | 1.08T |
| Beta Drugs | 11.41B |
| Tarsons Products | 10.54B |
| GPT Healthcare | 10.50B |
| Sakar Healthcare | 10.25B |